Senior Director, Early-Phase Oncology Programs

Jazz Pharmaceuticals; Palo Alto (CA); Remote; USD 230,000 - 346,000; Full time

Job summary

Jazz Pharmaceuticals is seeking a Senior Director, Head of Early Phase Program Management to lead strategic and operational efforts for late oncology and early-phase trials within Global Clinical Development Operations. The role partners with Clinical Development leadership to align study design, feasibility, and governance, ensuring timely, within-budget execution.

The incumbent will oversee multi-country trial portfolios, drive data-driven decisions, manage budgets and timelines, and build a

Qualifications

• Advanced degree in life sciences or related field; leadership in clinical operations preferred.
• Experience delivering global early-phase oncology trials; budgeting and governance oversight.
• Strong collaboration with Clinical Development, Regulatory, Biostatistics, and external partners.

Responsibilities

• Define the strategic vision for Late Oncology and Early Phase Program Management aligned with R&D goals.
• Lead governance, budgeting, and portfolio forecasting for global early-phase trials.
• Manage and develop a high-performing team of Clinical Operations Directors and Associate Directors.
• Partner with external CROs and internal stakeholders to ensure feasible, deliverable trial designs.

Skills

Strategic leadership

Clinical Operations

Budgeting

Program management

Cross-functional collaboration

Risk management

Leadership & people management

Education

Advanced degree (Ph.D., Pharm.D., M.S.) in life sciences

Bachelor’s degree with exceptional industry experience

Job description

Jazz Pharmaceuticals is seeking a Senior Director, Head of Early Phase Program Management to lead strategic and operational efforts for late oncology and early-phase trials within Global Clinical Development Operations. The role partners with Clinical Development leadership to align study design, feasibility, and governance, ensuring timely, within-budget execution.

The incumbent will oversee multi-country trial portfolios, drive data-driven decisions, manage budgets and timelines, and build a